MS, Pharmacy Administration
University of North Carolina, Chapel Hill, NC
Alicia Gilsenan, PhD, is a Senior Director of Epidemiology within RTI-HS and a licensed pharmacist. Dr. Gilsenan's primary area of expertise is pharmacoepidemiology and therapeutic risk management. Since joining RTI in 1997, she has applied state-of-the-art approaches to the design, conduct, and analysis of both retrospective and prospective epidemiologic studies focused on evaluating disease natural history and incidence of and risk factors for adverse outcomes potentially associated with the use of medications. She has directed multidisciplinary international teams for large primary data collection studies in the United States and Europe. Currently, she leads an international safety surveillance study and a US-based patient registry that are both part of a mandated risk management program. She is also involved in several Risk Evaluation and Mitigation Strategy (REMs) projects. Dr.Gilsenan has also led retrospective database studies designed to examine differences in risk factors and health care resource utilization between subgroups. She has led and conducted systematic reviews of the literature. Dr. Gilsenan has published within multiple therapeutic areas, including mental health, oncology, sexual functioning, cardiovascular health, respiratory health, and smoking cessation. Dr. Gilsenan is Adjunct Assistant Professor at the University of North Carolina at Chapel Hill School of Pharmacy.